These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27248906)

  • 21. Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes.
    Wulfert M; Küpper AC; Tapprich C; Bottomley SS; Bowen D; Germing U; Haas R; Gattermann N
    Exp Hematol; 2008 May; 36(5):577-86. PubMed ID: 18439489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of somatic mutations with outcome after FLAMSA-busulfan sequential conditioning and allogeneic stem cell transplantation in patients with myelodysplastic syndromes.
    Christopeit M; Badbaran A; Alawi M; Zabelina T; Zeck G; Wolschke C; Ayuk F; Kröger N
    Eur J Haematol; 2016 Sep; 97(3):288-96. PubMed ID: 26680262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of SRSF2-P95 mutation by high-resolution melting curve analysis and its effect on prognosis in myelodysplastic syndrome.
    Lin J; Yang J; Wen XM; Yang L; Deng ZQ; Qian Z; Ma JC; Guo H; Zhang YY; Qian W; Qian J
    PLoS One; 2014; 9(12):e115693. PubMed ID: 25541999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary myelodysplastic syndromes identified via next-generation sequencing in a non-small cell lung cancer patient.
    Feng Y; Chen X; Jiang K; Zhang D; Tao F; Ni D; Zhang J; Wu L; Cai J; Jiang L; Yu G; Shi L
    BMC Med Genomics; 2021 Dec; 14(1):299. PubMed ID: 34930266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA.
    Garcia-Gisbert N; Garcia-Ávila S; Merchán B; Salido M; Fernández-Rodríguez C; Gibert J; Fernández-Ibarrondo L; Camacho L; Lafuente M; Longarón R; Espinet B; Vélez P; Pujol RM; Andrade-Campos M; Arenillas L; Salar A; Calvo X; Besses C; Bellosillo B
    Blood Adv; 2022 May; 6(10):3178-3188. PubMed ID: 35192693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing.
    Baudhuin LM; Lagerstedt SA; Klee EW; Fadra N; Oglesbee D; Ferber MJ
    J Mol Diagn; 2015 Jul; 17(4):456-61. PubMed ID: 25960255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction in multi-lineage and erythroid progenitors distinguishes myelodysplastic syndromes from non-malignant cytopenias.
    Vercauteren SM; Bashashati A; Wu D; Brinkman RR; Eaves C; Eaves A; Karsan A
    Leuk Res; 2009 Dec; 33(12):1636-42. PubMed ID: 19414193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular genetics in myelodysplastic syndromes.
    Haferlach T
    Leuk Res; 2012 Dec; 36(12):1459-62. PubMed ID: 22986016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wilms' tumor-1 transcript in peripheral blood helps diagnose acute myeloid leukemia and myelodysplastic syndrome in patients with pancytopenia.
    Yamauchi T; Matsuda Y; Takai M; Tasaki T; Hosono N; Negoro E; Ikegaya S; Takagi K; Kishi S; Yoshida A; Urasaki Y; Ueda T
    Anticancer Res; 2012 Oct; 32(10):4479-83. PubMed ID: 23060576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis.
    Bae E; Park CJ; Cho YU; Seo EJ; Chi HS; Jang S; Lee KH; Lee JH; Lee JH; Suh JJ; Im HJ
    Int J Lab Hematol; 2013 Dec; 35(6):629-36. PubMed ID: 23693053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based survey.
    Pine AB; Chokr N; Stahl M; Steensma DP; Sekeres MA; Litzow MR; Luger SM; Stone RM; Greenberg PL; Bejar R; Bewersdorf JP; Gore SD; Zeidan AM
    Leuk Lymphoma; 2020 Jun; 61(6):1455-1464. PubMed ID: 32026740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
    Bernell P; Jacobsson B; Nordgren A; Hast R
    Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High incidence of apoptosis in peripheral blood of myelodysplastic syndrome patients determined by Papanicolaou-stained preparations.
    Emura I
    Lab Hematol; 2003; 9(1):42-6. PubMed ID: 12661827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA.
    Jilani I; Estey E; Manshuri T; Caligiuri M; Keating M; Giles F; Thomas D; Kantarjian H; Albitar M
    Leukemia; 2003 Jan; 17(1):114-9. PubMed ID: 12529667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.
    Sivakumaran TA; Husami A; Kissell D; Zhang W; Keddache M; Black AP; Tinkle BT; Greinwald JH; Zhang K
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1007-16. PubMed ID: 23525850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mutation of mitochondria cytochrome oxidase gene in patients with myelodysplastic syndrome].
    Hou L; Liu T; Meng WT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):809-12. PubMed ID: 18718066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of next-generation sequencing in routine diagnostics and management of patients with cytopenia.
    Breinholt MF; Nielsen K; Schejbel L; Fassi DE; Schöllkopf C; Novotny GW; Mortensen BK; Ahmad A; Høgdall E; Nørgaard P
    Int J Lab Hematol; 2022 Jun; 44(3):531-537. PubMed ID: 35142436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?
    Cherry AM; Slovak ML; Campbell LJ; Chun K; Eclache V; Haase D; Haferlach C; Hildebrandt B; Iqbal AM; Jhanwar SC; Ohyashiki K; Sole F; Vandenberghe P; VanDyke DL; Zhang Y; Dewald GW
    Leuk Res; 2012 Jul; 36(7):832-40. PubMed ID: 22537394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Next-generation sequencing and its application in acute myeloid leukemia and myelodysplastic syndrome].
    Gu SC; Chang CK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1545-9. PubMed ID: 22169322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.